InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,797.64
(
0.61%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
-0.63%
)
Bitcoin
57,819.42
(
0.82%
)

Replies to post #440297 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #440297 on NorthWest Biotherapeutics Inc (NWBO)
icon url

Dr Bala

02/01/22 12:28 PM

#440298 RE: It Is What It Is #440297

Totally nonsensical speculation.
icon url

norisknorewards

02/01/22 12:29 PM

#440299 RE: It Is What It Is #440297

do us all a favor, sell.
icon url

flipper44

02/01/22 12:39 PM

#440304 RE: It Is What It Is #440297

Completely different situation. That involved Rhett syndrome, not cancer, and the company recently changed the endpoint from a biological endpoint to a survey endpoint. The market punished them.

Note: It was stupid, (hear that NWBO?) for AVXL to change their clinical registry a few days before announcement.
icon url

The Danish Dude

02/01/22 12:47 PM

#440306 RE: It Is What It Is #440297

Another company that changed the trial endpoints post-facto. Whoops. This is not a good indicator for NWBO.



Can I recommend you read about what has happened after data lock 2020?

Just to get acquainted with the most basic stuff?